Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: A prospective multicenter study

Định dạng: PDF / Số trang: 11

Nhắn tin với admin nếu không tải được